Rallybio Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Rallybio Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 95% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-317.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 95% of Healthcare companies in United States.
Cash Cushion Ratio
+63%Cash, after subtracting all debt, equals 63% of its market value (net cash).
Higher than 81% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Rallybio Corporation owes $0.04 for every $1 it owns. Rallybio Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
2.0Investors pay $2.0 for every $1 of Rallybio Corporation's yearly profit, lower than 90% of Healthcare companies in United States.
P/B ratio
0.92The share price is 0.92 times Rallybio Corporation's book value per share, lower than 80% of Healthcare companies in United States.
Market cap
$87 MThe total market value of all of Rallybio Corporation's shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$94 MWhat Rallybio Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$17.79Net worth divided by the number of shares. The share price of $16.40 is 0.9 times this, which is the P/B above.
Return on equity (ROE)
64.9%Rallybio Corporation earned 64.9% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
Owes vs Owns
0.04×Rallybio Corporation owes $0.04 for every $1 it owns (low), lower than 98% of Healthcare companies in United States.
Dividend yield
NoneRallybio Corporation does not currently pay a dividend.
Revenue growth
+35%Revenue rose 35% in the year to Dec 2025.
Profit growth
LossRallybio Corporation made a loss in each of the last two years.
Profit margin
-1046.4%Rallybio Corporation lost $1046 for every $100 of revenue.
Cash vs debt
Net cashRallybio Corporation held $55 M more cash than debt (net cash) at Dec 2025.
Questions
What is Rallybio Corporation's P/E ratio?
Investors pay $2.0 for every $1 of Rallybio Corporation's yearly profit, lower than 90% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Rallybio Corporation: $87 M ÷ $94 M (30 Jun 2026) = 0.9.
What is Rallybio Corporation's return on equity?
Rallybio Corporation earned 64.9% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
How much does Rallybio Corporation owe compared with what it owns?
Rallybio Corporation owes $0.04 for every $1 it owns (low), lower than 98% of Healthcare companies in United States.
Does Rallybio Corporation pay a dividend?
No. Rallybio Corporation does not currently pay a dividend.
Is Rallybio Corporation's revenue growing?
Revenue rose 35% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.